Challenging Cases in Cervix Cancer - 2021 Annual Meeting
This course presents challenging cases of women with cervix cancer, either due to poorly studied disease subsets (e.g. paraortic nodal disease management and nodal recurrent disease) , newer advances in standard intracavitary brachytherapy( eg hybrid brachytherapy indications and implementation), technically challenging distributions of disease (e.g. IIIA and IVA cervix cancer needing complex interstitial brachytherapy) or newly controversial subjects in when and how radiation therapy should be used and integrated with systemic therapy (e.g. oligometastatic and oligoprogressive recurrent cervix cancer).
Topics of particular interest are how to integrate SAbR with targeted therapy for cervix cancer and use of complex image guided interstitial brachytherapy for locally advanced cervical cancer. The organizers solicited cases from social media (Mednet, chartrounds RO Hub) to engage attendees more thoroughly before, during, and after the session. A significant amount of time is also spent in presenting to engage the audience for cases from their practice that may be helpful for the rest of the attendees to hear.
This activity is available from January 10, 2022, through 11:59 p.m. Eastern time on January 9, 2025.
This activity was originally recorded at ASTRO’s 2021 Annual Meeting, October 24-27th.
The activity is designed to meet the interests of radiation oncologists, radiation oncology residents, surgeons, nurses, radiation therapists, radiation dosimetrists, radiation physicists and medical oncologists.
Upon completion of this activity, participants should be able to:
- Explain the rationale and choice for radiation therapy in cervix cancer with extensive nodal disease.
- Determine the best brachytherapy treatment options for assymetric large primary cervical cancers and choice of hybrid brachytherapy technique AND image-based complex interstitial brachytherapy approach for Stage IIIA and IV A cervix cancer.
- Determine the ideal approach for integrating radiation and systemic therapy for cervix cancer cancer.
- Kevin Albuquerque, MD, Department of Radiation Oncology, University of Texas Southwestern Medical Center receives compensation from ACR, ARRT, ASCO, and AstraZeneca.
- Hina Saeed, MD, Department of Radiation Oncology, Medical College of Wisconsin has no financial relationships with a commercial interest.
- Umesh M. Mahantshetty, MD, Tata Memorial Hospital, Tata Memorial Centre, Homi Bhabha National Institute has no financial relationships with a commercial interest.
- Eric W. Leung, MD, Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto has no financial relationships with a commercial interest.
- Michelle S. Ludwig, MD, PhD, MPH, Department of Radiation Oncology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine and Department of Radiation Oncology, Baylor College of Medicine has no financial relationships with a commercial interest.
The person(s) above served as the developer(s) of this activity. Additionally, the Education Committee had control over the content of this activity. All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.